Leptin regulates AMPA receptor trafficking via PTEN inhibition by Moult, Peter R. et al.
Cellular/Molecular
Leptin Regulates AMPA Receptor Trafficking via PTEN
Inhibition
Peter R. Moult,1 Alasdair Cross,1 Sandra D. Santos,3 Ana-Luisa Carvalho,3 Yvonne Lindsay,2 Christopher N. Connolly,1
Andrew J. Irving,1Nicholas R. Leslie,2 and Jenni Harvey1
1Centre for Neuroscience, Division of Medical Sciences, Ninewells Hospital, and 2Department of Molecular Physiology, University of Dundee, Dundee DD1
9SY, United Kingdom, and 3Center for Neuroscience, Department of Zoology, University of Coimbra, 3004-504 Coimbra, Portugal
The hormone leptin can cross the blood–brain barrier and influences numerous brain functions (Harvey, 2007). Indeed, recent studies
havedemonstrated that leptin regulates activity-dependent synaptic plasticity in theCA1 regionof thehippocampus (Shanley et al., 2001;
Li et al., 2002; Durakoglugil et al., 2005; Moult et al., 2009). It is well documented that trafficking of AMPA receptors is pivotal for
hippocampal synaptic plasticity (Collingridge et al., 2004), but there is limited knowledge of how hormonal systems like leptin influence
this process. In this studywe have examined how leptin influences AMPA receptor trafficking and in turn how this impacts on excitatory
synaptic function. Here we show that leptin preferentially increases the cell surface expression of GluR1 and the synaptic density of
GluR2-lacking AMPA receptors in adult hippocampal slices. The leptin-induced increase in surface GluR1 required NMDA receptor
activation andwas associatedwith an increase in cytoplasmic PtdIns(3,4,5)P3 levels. In addition, leptin enhanced phosphorylation of the
lipid phosphatase PTEN which inhibits PTEN function and elevates PtdIns(3,4,5)P3 levels. Moreover, inhibition of PTENmimicked and
occluded the effects of leptin on GluR1 trafficking and excitatory synaptic strength. These data indicate that leptin, via a novel pathway
involving PTEN inhibition, promotes GluR1 trafficking to hippocampal synapses. This process has important implications for the role of
leptin in hippocampal synaptic function in health and disease.
Introduction
Glutamate is the main excitatory neurotransmitter in the mam-
malian CNS, and a key feature of neuronal networks is the ability
to dynamically alter excitatory synaptic strength. Indeed, hip-
pocampal synaptic plasticity is thought to underlie learning and
memory (Bliss and Collingridge, 1993). AMPA receptor traffick-
ing is pivotal for rapid forms of hippocampal synaptic plasticity
(Collingridge et al., 2004) such as long-term potentiation (LTP)
and long-term depression (LTD). However, little is known about
how such events are regulated by hormones or altered in patho-
logical states. Recent studies have shown that tumor necrosis
factor- (TNF-) increases AMPA receptor surface expres-
sion (Stellwagen andMalenka, 2006), whichmay contribute to
its role in mediating brain damage from pathological insults.
Insulin also alters AMPA receptor trafficking and synaptic
function (Passafaro et al., 2001; Zhou et al., 2001), and defects
in insulin-driven processes are linked to neurodegenerative
disorders such as Alzheimer disease.
AMPA receptor trafficking is dependent on phosphoinositide
3-kinase (PI 3-kinase; Man et al., 2003), an ubiquitous enzyme
that promotes phosphorylation of PtdIns(4,5)P2 to generate
PtdIns(3,4,5)P3 (Cantley, 2002). Thus, PI 3-kinase–driven eleva-
tions in PtdIns(3,4,5)P3 may contribute to alterations in AMPA
receptor trafficking. The tumor suppressor PTEN (phosphatase
and tensin homolog deleted on chromosome 10) limits PI
3-kinase-dependent signaling by dephosphorylating PtdIns(3,4,5)P3
into PtdIns(4,5)P2 (Maehama and Dixon, 1998). PTEN contains
a tyrosine phosphatase functional domain, exhibiting both pro-
tein phosphatase and lipid phosphatase activity in vitro. In most
cells, PTEN is constitutively active and influences the basal levels
of PtdIns(3,4,5)P3. However, inhibition of PTEN activity by re-
active oxygen species and phosphorylation leads to modified PI
3-kinase-dependent signaling (Downes et al., 2007). In pancre-
atic  cells and a hypothalamic cell line the hormone leptin also
promotes phosphorylation of PTEN, resulting in inhibition of
PTEN activity and an increase in PtdIns(3,4,5)P3 levels (Ning et
al., 2006).
Evidence is growing that leptin influences numerous neuronal
functions (Harvey, 2007). Leptin regulates energy homeostasis
via its hypothalamic actions (Spiegelman and Flier, 2001). Recent
studies have implicated leptin in hippocampal synaptic plasticity
as leptin-insensitive rodents display impaired LTP and LTD and
spatial memory (Li et al., 2002). Administration of leptin into
rodent hippocampus improves memory processing (Wayner et
al., 2004). Moreover, leptin facilitates LTP (Shanley et al., 2001)
and evokes NMDA receptor-dependent LTD (Durakoglugil et
al., 2005). However, it is not known whether leptin influences
AMPA receptor trafficking and in turn how this impacts on ex-
citatory synaptic function. Here we provide the first compelling
evidence that leptin rapidly increases GluR1 surface expression
and promotes an increase in the synaptic expression of GluR2-
lacking AMPA receptors in adult hippocampus. The increase in
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GluR1 trafficking by leptin is associated with an increase in
PtdIns(3,4,5)P3 levels. This is accompanied by increased phos-
phorylation of PTEN, an action resulting in PTEN inactivation
and increased PtdIns(3,4,5)P3 levels. Indeed, PTEN inhibition
mimicked and occluded the effects of leptin on GluR1 trafficking
to synapses, indicating the involvement of PTEN inhibition.
These findings have important implications for the role of leptin
and PTEN in regulating hippocampal synaptic strength.
Materials andMethods
Hippocampal cell culture. Hippocampal cultures were prepared as before
(Shanley et al., 2001). Briefly, neonatal Sprague-Dawley rats (1–3 d old)
were killed by cervical dislocation in accordance with Schedule 1 of UK
Animals (Scientific Procedures) Act, 1986. Hippocampi were removed
and after washing in HEPES buffered saline containing the following (in
mM): 135NaCl; 5KCl; 1CaCl2; 1MgCl2; 10HEPES; 25 D-glucose, pH7.4,
were treated with protease type X and type XIV (0.5 mg/ml; Sigma)
for 25 min at room temperature. Dissociated cells were plated onto
sterile dishes (Falcon 3001) treated with poly-L-lysine (20 gml-1;
1–2 h). Cultures were maintained in serum replacement medium
(SR2; Sigma) in a humidified atmosphere of 5% CO2 and 95% O2 at
37°C for up to 3 weeks.
Transfection protocol. Cells were transfected with PTEN C124S or
PTEN G129E in EGFP-C2 or empty vector, EGFP-C2, using lipo-
fectamine 2000 (L2K). L2K was mixed withMEM (ratio of 3l L2K: 100
l MEM), and the desired plasmid was mixed with Optimem (ratio of 2
g plasmid: 100 l Optimem. After 5 min the diluted L2K and plasmid
were mixed and left at room temperature for 20 min. 200 l L2KDNA
mixwas added to each coverslip of neurons (6–10DIV) in 1ml of culture
media. Cells were returned to the incubator for 1 h, before washing.
Transfected cells were used 24–48 h after transfection.
Immunocytochemistry and analysis. Immunocytochemistry was per-
formed on 7- to 12-d-old cultured hippocampal neurons after treatment
with vehicle or leptin (50 nM) for 30 min at 21–23°C. To label surface
GluR1 or GluR2, living neurons were incubated with antibodies against
N-terminal regions of GluR1 (sheep anti-GluR1; in house antibody
against synthetic peptide (RTSDSRDHTRVDWKR) corresponding to
253–267 residues of GluR1; Pickard et al., 2001; 1:100) and GluR2
(mouse anti-GluR2; Zymed; 1:250) at 4°C. Cultures were fixed with 4%
paraformaldehyde (10 min) which did not permeabilize cells as assayed
by the absence of microtubule-associated protein 2 (MAP2) staining.
Surface GluR1 or GluR2 staining was visualized by addition of appropri-
ate Alexa 488- or Cy3-conjugated secondary antibodies (1:250; Stratech
Scientific, UK) for 30 min. No labeling was observed after incubation
with secondary antibodies alone. In some studies, cells were permeabil-
ized with 0.1% Triton X-100 (5 min) to compare staining relative to
synapsin-1 (mouse anti-synapsin-1; 1:250; 30 min; BD Biosciences),
PTEN (mouse anti-PTEN; 1:500; 30 min; Cascade Biosciences) or
PtdIns(3,4,5)P3 (mouse PtdIns(3,4,5)P3; 1:500; 1 h; Echelon) labeling.
For synaptic colocalization, surface GluR1 staining was compared with
synapsin-1 and percentage of surface GluR1 at synapses was assessed as
number of GluR1-positive sites that colocalizedwith synapsin-1-positive
sites.
For global PTEN immunolabeling, neurons were fixed, washed with
HEPES-buffered saline (HBS), and then permeabilized. Neurons were
treated with primary antibody (mouse anti-PTEN; clone 6H2.1; 1:500)
for 30 min at room temperature. After washing, neurons were incubated
with donkey anti-mouse antibody (1:250; 30min). In dual labeling stud-
ies, the anti-GluR1 antibody (above) was used to assess distribution at
somato-dendritic regions or antibody against an N-terminal epitope of
CB1 receptor (gift fromK.Mackie, IndianaUniversity, Bloomington, IN;
1:100; 1 h; Coutts et al., 2001) to determine PTEN distribution on axons.
Living neurons were incubated with either of these antibodies before
fixation and incubation with a secondary antibody. PTEN distribution
was examined after neurons were permeabilized.
For P366-PTEN or P385-PTEN immunostaining, neurons were fixed,
permeabilized, and then incubated with a sheep anti-P366 PTEN anti-
body (1:500; Maccario et al., 2007) or rabbit anti-P385 PTEN antibody
(1:500; Biosource) for 30 min. In dual labeling studies, markers for en-
dosomes (mouse anti-RAB5; 1:500; or rabbit anti-RAB7; 1:500; Sigma),
the Golgi apparatus (mouse anti-mannosidase II; 1:1000; Covance),
P385 PTEN (rabbit anti-P385 PTEN; 1:500; Biosource), or PtdIns(3,4,5)P3
(above)were used.
Analysis. A confocal imaging system (Zeiss LSM 510) was used for
image acquisition. Laser lines (488 and 543 nm)were used to excite Alexa
488 and Cy3 fluorophores, respectively. Dual labeling images were ob-
tained inmultitrackingmodeusing a 15 s scan speed. Intensity of staining
was determined off-line using Lasersharp software (Carl Zeiss). Analysis
lines (50m) were drawn along randomly selected dendritic regions (50
nm), andmean fluorescence intensitywas calculated.Datawere obtained
from at least three randomly selected cells for each condition, and all data
were obtained from at least three different cultures from different ani-
mals. Within a given experiment, all conditions, including illumination
intensity and photomultiplier gains, were kept constant. To quantify
experimental data obtained from separate days, data were normalized
relative to mean fluorescence intensity in control neurons. In a subset of
control experiments indicated in the text, both surface and total GluR1
were labeled and changes in surface GluR1 calculated as a function of
total GluR1. All data are expressed as means  SEM, and statistical
analyses were performed using Student’s unpaired t test for comparison
of means, or ANOVA for comparisons between multiple groups. p 
0.05 was considered significant.
Hippocampal slice preparation and electrophysiology. Hippocampal
slices (350 m) were prepared from 12- to 16-week-old male, Sprague-
Dawley rats or Zucker lean or fa/fa rats. Animals were killed by cervical
dislocation according to UK (Scientific Procedures) legislation. Brains
were rapidly removed and placed in ice-cold artificial CSF (aCSF; bub-
bled with 95% O2 and 5% CO2) containing the following (in mM): 124
NaCl, 3 KCl, 26 NaHCO3, 1.25 NaH2PO4, 2 CaCl2, 1 MgSO4, and 10
D-glucose.Onceprepared,parasagittal sliceswereallowed to recover at room
temperature inoxygenated aCSF for 1hbeforeuse. Sliceswere transferred to
a submerged chambermaintained at 30–31°C and perfusedwith aCSF con-
taining the GABAA receptor antagonist, picrotoxin (50M), at a rate of 2–3
ml  min1. Blind whole-cell recordings from stratum pyramidale of area
CA1were obtained using electrodes (4–7M) containing the following (in
mM): 130 Csmethanesulphonate, 5 NaCl, 1 CaCl2, 5 HEPES, 1 EGTA, 5
Mg-ATP, 0.5 Na-GTP, and 5 QX-314, pH 7.3. Where 10 mM BAPTA was
included in the filling solution, EGTA was absent and the concentration of
Csmethanesulphonate adjusted tomaintain osmolarity. Unless otherwise
stated cells were voltage clamped at 60 mV. The Schaffer collateral-
commissural pathwaywas stimulated at 0.033Hz, using a stimulus intensity
that evoked a peak amplitude 50% of the maximum. Synaptic currents
were low pass filtered at 2 kHz and digitally sampled at 10 kHz. The mean
series resistance for all cells was 23 3M (n 112).
Data were monitored online and analyzed off-line using the WINltp
program (Anderson and Collingridge, 2007). The degree of potentiation
was calculated 40–45 min after addition of leptin or bpV and expressed
as a percentage of baseline. The paired pulse ratio (PPR)was calculated as
ratio of amplitude of second EPSC to first EPSC. To ensuremeasurement
of second EPSC was not contaminated, the residual component of first
EPSCwas removed (Moult et al., 2009). The coefficient of variation (CV)
was calculated as before (Moult et al., 2009). Briefly, the mean and SD
were calculated for EPSC amplitudes recorded during successive 5 min
epochs (SDEPSC and meanEPSC). The SD of background noise was calcu-
lated for each 5 min epoch using a period immediately before electrical
stimulation (SDnoise). The CV for each 5 min epoch was calculated as
(SDEPSC SDnoise)/meanEPSC. For calculation of RI, 0.1 mM spermine
was included in the pipette solution. Cells were depolarized to 40
mV for 2 min (four successive stimulations) before leptin or bpV
application, and this was repeated at the peak of their effects. The
rectification index (RI) was calculated as the ratio of the initial slopes
of the EPSCs: EPSChyperpolarised/EPSCdepolarized.
Whole-cell recordings from hippocampal cultures. Whole-cell record-
ings from pyramidal neurons were obtained as previously detailed. Cells
were voltage clamped at60 mV using the same intracellular solutions
used for recording from hippocampal slices. Cells were perfused contin-
uously withHBS of the following composition (inmM): 119NaCl, 5 KCl,
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2CaCl2, 2MgCl2, 25HEPES, 33 D-glucose, 0.005 tetrodotoxin citrate, 0.1
picrotoxin, and 0.001 glycine, pH 7.4, at a rate of 2–3 ml  min1. Leptin
was applied by addition to the HBS perfusate. Data were filtered at 2 kHz
and digitized at 10 kHz. Continuous recording of miniature EPSCs
(mEPSCs) was made using the WinLTP program (Anderson and Col-
lingridge, 2007). mEPSC detection was performed using MiniAnalysis
software (Synaptosoft). Events were detected by setting the threshold
value for detection at three times the level of the root mean square noise,
followed by visual confirmation ofmEPSCdetection. For construction of
cumulative probability plots, 400 successive events were used from the
period immediately preceding application of leptin and from the period
before 20 min after commencing washout of leptin. For pooled cumula-
tive probability plots, data were normalized to the median value in the
preleptin period.
Western blotting for P366 experiments. Samples were processed for
Western blotting as previously described (Maccario et al., 2007). Briefly,
after exposure of slices to either leptin or control media, slices were
homogenized in ice-cold lysis buffer consisting of 25mMHEPES, 150mM
NaCl, 1% Triton X-100, 0.1% 2 mercaptoethanol, 1 mM EDTA, 1 mM
EGTA, 10 mM  glycerophosphatase, 50 mM sodium fluoride, 10 g/ml
leupeptin, 100 M PMSF, and 1 mM benzamidine. Proteins were sepa-
rated by PAGE using precast 4–12% gradient gels and blotted onto poly-
vinylidene difluoride (PVDF)membranes (Polyscreen:NEN/PerkinElmer).
Immunoprecipitation of PTEN used the A2B1 monoclonal antibody
(Santa Cruz Biotechnology), preconjugated with agarose beads. Immu-
noprecipitation of P366 PTEN used the phospho-specific antibody
against PTEN phosphor-Thr366 synthesized by Dr. Graham Bloomberg
(Molecular Recognition Centre, University of Bristol, Bristol, UK).
Quantification was made using AIDA image analysis software. Each ex-
periment was done in triplicate, and data were normalized to control
values within each experiment and then expressed asmean percentage of
normalized control SE of mean.
Cell surface protein biotinylation in hippocampal slices. Hippocampal
slices (350 m) obtained from Sprague-Dawley rats 3–4 weeks old and
13–16 weeks old and Zucker lean and fa/fa rats (13–16 weeks old) were
used (Thomas-Crusells et al., 2003). Zucker fa/fa rats contain amutation
( famutation) in the extracellular region of the leptin receptor, resulting
in resistance to exogenous administration of leptin. Slices (three slices
per condition) were incubated for 15 min at 37°C in aCSF (control con-
dition), or 25 nM leptin and 50M picrotoxin in aCSF, under continuous
gasification with 95% O2 and 5% CO2. Slices were transferred to aCSF
solution containing 0.3 mg/ml NHS-SS-biotin (Pierce) and kept on ice
with agitation for 45 min. Slices were then incubated in aCSF with 1 M
lysine to block all reactive NHS-SS-biotin in excess. Slices were then
collected in 500 l of lysis buffer (1% Triton X-100, 0.1% SDS, 1 mM
EDTA, 50 mM NaCl, 20 mM Tris, pH 7.5, supplemented with 1 mM DTT
and a mixture of protease inhibitors—0.1 mM PMSF; 1 g/ml chymo-
statin, 1 g/ml leupeptin, 1 g/ml antipain, 1 g/ml pepstatin) and
sonicated on ice for 30 s. To discard extra debris, homogenates were
centrifuged for 5 min at 4°C at 13,000 rpm and supernatants collected.
Protein concentration was quantified by the BCA method (Pierce), and
the same amount of protein (500–750 g) was used in all experimental
conditions. To precipitate biotinylated proteins, 40 l of Ultra-link im-
mobilized neutravidin plus beads were added to samples for 2 h at 4°C,
under constant agitation. Nonbiotinylated proteins were removed by
centrifugation at 2500 g for 2 min, and beads were washed three times
with lysis buffer. Biotinylated proteins were eluted with denaturing
buffer at 95°C for 5 min. Samples were processed for Western blotting
analysis with the sheep anti-GluR1 antibody (1:750) or rabbit anti-GluR2
antibody (1:600). Alkaline phosphatase-conjugated secondary antibod-
ies were used, and alkaline phosphatase activity was visualized by en-
hanced chemifluorescence (ECF) on Storm 860 Gel and Blot Imaging
System (GE Healthcare). Scanned digital images were quantified using
ImageQuant 5 software (GE Healthcare). Results are presented as
means SEM of number of experiments performed in different prep-
arations. Statistical significance was determined by the Student t test
(*p  0.05).
Materials. Recombinant human leptin (R&D Systems Europe) was
used in all experiments. LY294002, wortmannin, bisperoxovanadium
(Calbiochem), and D-AP5 (Tocris Cookson) were all obtained
commercially.
Statistical analyses. All data are expressed as means SEM, and statis-
tical analyses were performed using paired t test (two-tailed; 95% confi-
dence interval) for comparison ofmeans or two-way ANOVA (ANOVA)
with Tukey post hoc test for comparisons between multiple groups (un-
less otherwise stated). p 0.05 was considered significant.
Results
Leptin differentially regulates the surface expression of
GluR1 and GluR2
To determine whether leptin alters the density of AMPA recep-
tors, the cell surface expression of AMPA receptors was assayed
using anN-terminal antibody againstGluR1on living hippocam-
pal neurons (Fig. 1A,B). Leptin (50 nM; 30min) induced a robust
increase (154 4.9% of untreated cultures; n 78; p 0.01) in
GluR1 surface expression. This effect was due to leptin as appli-
cation of the inactive boiled peptide failed to alter GluR1 surface
staining (103 1.2% of control; n 9; p	 0.05).
In hippocampal pyramidal cells, endogenous AMPA recep-
tors consist of GluR1 and GluR2 subunits. To examine whether
leptin influenced GluR2 surface expression, dual labeling ap-
proaches were used to compare the effects of leptin on GluR1
versus GluR2. Leptin (1–50 nM; 30 min) produced a concen-
tration-dependent increase in GluR1 surface staining (Fig. 1B).
Thus, 1 nM leptin increased surfaceGluR1 staining to 115 5.1%
of control (n 27; p 0.05) whereas 50 nM leptin resulted in an
increase to 144 5.7% (n 34; p 0.01). In contrast, leptin was
less potent at alteringGluR2 surface expression (Fig. 1B). At 1 nM
(106  3.6% of control; n  27; p 	 0.05) and 10 nM (109 
4.0%; n 29; p	 0.05), leptin failed to evoke a significant change
in surface GluR2 staining, however at higher concentrations, lep-
tin increased GluR2 staining to 121  5.4% of control (n  37;
p 0.01).
Leptin increases the density of GluR1 subunits at
hippocampal synapses
As the circulating leptin levels are in the low nanomolar range
(Caro et al., 1996), the GluR1 subunit is likely to be the main
target for leptin under physiological conditions. As the surface
expression of receptors is a balance between exocytotic and en-
docytotic mechanisms, the increase in surface GluR1 expression
by leptin could be due to alterations in either process. To deter-
mine whether leptin alters GluR1 exocytosis, we examined the
effects of two inhibitors namely NEM, a broad spectrum in-
hibitor of N-ethylmaleimide-sensitive fusion protein (NSF)
and brefeldin A (Fig. 1C). Application of NEM (5 mM; 40 min;
n  27) or brefeldin A (5 M; 40 min; n  27) had no signif-
icant effect on GluR1 surface expression per se. However,
prior exposure to either agent attenuated the effects of leptin
as the increase in GluR1 surface staining induced by leptin (to
141  4%; n  27) was reduced to 104  6% of control (n 
27; p	 0.05) and 113 5% of control (n 27; p	 0.05) in the
presence of NEM or brefeldin A, respectively. These data in-
dicate that leptin increases GluR1 surface density by promot-
ing GluR1 exocytosis.
The strength of excitatory synaptic transmission is dependent
on the density of AMPA receptors expressed at synapses. To as-
sess whether leptin influences the synaptic localization of GluR1,
we compared the distribution of surface GluR1 relative to syn-
apses (anti–synapsin-1 antibody) using immunocytochemistry,
and the percentage colocalization was evaluated. In accordance
with our previous findings (O’Malley et al., 2007), leptin in-
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creased synapsin-1 staining to 113.4 4%
of control (n  21; p  0.05). Moreover
leptin increased surface GluR1 that colo-
calized with synapsin-1 staining from
33.7 2.6% to 48.9 3.1% (n 21; p
0.05) (Fig. 1D). These data indicate that
leptin promotes the synaptic expression
of GluR1.
To determine directly how the immu-
nocytochemical findings from hippocam-
pal cultures relate to excitatory synaptic
transmission, we assessed initially at what
stage of development the effects of leptin
on acute hippocampal slices mirrored
those observed effects in culture. Thus, in
parallel studies, we examined the effects of
leptin on AMPA receptor expression in
hippocampal slices using cell surface bi-
otinylation assays. Exposure of adult slices
(13–16 weeks old) to leptin (25 nM; 15
min) increased GluR1 (129  9.5% of
control; n  6; p  0.05) but not GluR2
(104 7.9% of control; n 6; p	 0.05)
surface expression. Application of leptin
(25 nM; 15 min) to younger slices (3–4
weeks old) had no effect on GluR1 (94
12% of control; n 3; p	 0.05) or GluR2
(88  21% of control; n  3; p 	 0.05)
surface expression (Fig. 1Ei,Eii). It is well
documented that Zucker fa/fa rats con-
tain a mutation in the leptin receptor that
renders them leptin-insensitive. Thus, to
determine whether leptin receptor activa-
tion was required, we also examined the
effects of leptin on GluR1 and GluR2 ex-
pression in hippocampal slices from adult
Zucker fa/fa or lean rats using cell surface
biotinylation assays. In agreement with
results from adult (13- to 16-week-old)
rats, exposure of slices from Zucker lean
rats to leptin (25 nM, 15 min) increased
GluR1 (128 13%, n 9/3; p 0.05) but
not GluR2 (94 14%, n 9/3; p	 0.05)
surface expression. In contrast, exposure
of slices from fa/fa rats to leptin had no
effect on either GluR1 (91  15%, n 
9/3; p	 0.05) or GluR2 (107 15%, n
9/3; p 	 0.05) surface expression (Fig.
1Fi,Fii). Thus, these data indicate that
leptin receptor activation is required for
the increase in GluR1 surface expression.
To determine the consequences for
hippocampal synaptic function, the ef-
fects of leptin on EPSCs were examined in
adult (13- to 16-week-old) slices. Applica-
tion of 25 nM leptin (15 min) produced a
robust enhancement of EPSCs to 197 
10% (n  6; p  0.001) of baseline (Fig.
2A,B), which was maintained for the du-
ration of recordings (up to 90 min).
Changes in paired pulse ratio (PPR) or the
CV classically reflect alterations in release
probability (Pr). To identify the locus of
Figure 1. Leptin increases the surface expression of AMPA receptors. A, Representative confocal images of surface (green) and total
(blue) GluR1 staining in control and leptin-treated hippocampal neurons. Leptin (50 nM; 30min) increased GluR1 surface labeling. Scale
bars, 10m.B, Pooled data showing the concentration-dependent effects of leptin on GluR1 (open bars) and GluR2 (filled bars) surface
expression.C,Pooleddatashowingrelativechanges insurfaceGluR1 labeling incontrol conditions,afterexposureto leptin (50nM),NEM(5
mM), brefeldin A (5M), and in the presence of either NEM or brefeldin A and leptin.D, Representative images of surface GluR1 staining
(green) and synapsin-1 staining (red) in control and leptin-treated neurons. Leptin (50 nM; 30 min) increased GluR1 surface labeling
associated with synapses. E, F, Surface expression of AMPA receptors as determined using cell surface biotinylation. Top, Representative
Western blots of surface GluR1 and GluR2 in control and leptin-treated slices from 3- to 4-week-old (Ei) and 13- to 16-week-old (Eii)
Sprague-Dawley rats and from13- to 14-week-old Zucker lean (Fi) and fa/fa (Fii) rats. Bottom, Correspondinghistogramsof GluR1 (filled
bars)andGluR2(openbars)surfaceexpression incontrol conditionsandafter treatmentwith leptin(25nM;15min). Inthisandsubsequent
figures *, **, and *** represent p 0.05, p 0.01, and p 0.001, respectively.
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this effect of leptin we analyzed PPR and
CV in the above experiments, by deliver-
ing two pulses at an interval of 50 ms. The
leptin increase in EPSC amplitudewas not
accompanied by any significant change
in PPR (n 6; p	 0.05) (Fig. 2C) or CV
(n 6; p	 0.05) (Fig. 2D), indicating the
likely involvement of a postsynaptic ex-
pression mechanism rather than altered
Pr. The effects of leptin were also exam-
ined in slices from leptin-insensitive rats
(Zucker fa/fa) and in lean animals (12–16
weeks old). Leptin (25 nM) increased
EPSC amplitude to 190 14% of control
(n 6; p 0.05) in Zucker lean animals,
but it had no significant effect on EPSCs
(102  6% of control) in fa/fa animals
(n 6; p	 0.05) (Fig. 2E), indicating that
leptin receptor activationwas required for
the effects of leptin.
GluR2-lacking AMPA receptors are
Ca2-permeable and display pronounced
inward rectification (Koh et al., 1995) that
is due to high affinity voltage-dependent
block of the channel by endogenous poly-
amines at positive membrane potentials.
To determine whether leptin alters the
GluR2 content of synaptic AMPA recep-
tors, the rectification properties of EPSCs
were monitored during whole-cell re-
cordings with spermine-containing pi-
pettes, as described previously (Moult et
al., 2009). Application of leptin (25 nM; 15
min) increased EPSC amplitude to 186
10% of control (n  6), and this was ac-
companied by an increase in rectification
index (RI) from 1.3  0.2 to 2.2  0.3
(n  6; p  0.05) (Fig. 2F–H). In inter-
leaved control experiments, no significant
change in RI was detected using spermine-
lacking pipettes (n  6; p 	 0.05) (Fig.
2G,H). Application of philanthotoxin (1
M), a selective inhibitor of GluR2-
lacking AMPA receptors, blocked the in-
serted receptors resulting in a decrease in
synaptic transmission (from 212  12%
of control) to 110 12% (n 6; p 0.05)
(Fig. 2 I). These data are consistent with
leptin increasing the density of GluR2-
lacking AMPA receptors at hippocampal
synapses.
Our data indicate that leptin increases
GluR1 surface expression by promoting
GluR1 exocytosis. Thus, we examined
whether the increase in synaptic strength
induced by leptin involved increased
GluR1 exocytosis, by inclusion of inhibi-
tors of exocytosis in the pipette (Fig. 2 J).
BothNEM (5mM) and brefeldin A (5M)
attenuated the potentiation caused by leptin (105  8%; n  6;
p	 0.05 and 112 8%; n 6; p	 0.05, respectively). The effects
of bafilomycin (1 M), an inhibitor of endocytosis, were also ex-
amined. In neurons dialyzed with bafilomycin, leptin resulted in a
166 7% increase in EPSC amplitude (n 6; p 0.01); an effect
not significantly different from control ( p	 0.05). These data are
consistent with leptin increasing synaptic strength via promoting
GluR1 exocytosis.
Figure 2. Leptin increases the synaptic density of GluR2-lacking AMPA receptors. A, Representative experiment showing that leptin
potentiatesEPSCsinhippocampalslices. Inthisandsubsequentfigures,eachpoint istheaverageoffoursuccessiveresponses.Top,Example
traces from the experiment are shown for the time points indicated. Calibration: 50 pA, 50 ms. B, Pooled and normalized data from all
experiments. In this and subsequent figures, data aremean EPSC amplitude SEM. C,D, PPR (C) and CV (D) calculated throughout the
samesetofexperimentsshowsnosignificantchange.E,Theleptin-inducedincreaseinsynapticstrengthrequiresleptinreceptoractivation.
Pooled and normalized data demonstrating that application of leptin (25 nM) induces potentiation of EPSCs in hippocampal slices from
Zucker lean rats (filled circles), but not in slices from Zucker fa/fa rats (open circles). F, Summary data of recordingsmadewith spermine-
containingpipettes. Interleavedcontrolexperimentsusingintracellularsolutionlackingsperminearealsoshown.Cellsweredepolarizedto
40mVfortimesindicated(graybars).G,ExampleEPSCsfromarepresentativeexperimentinF.EPSCsareshownforcontrolandspermine
experiments. Calibration: 50pA,50ms.H, Leptin-induced increases inEPSCamplitudeareassociatedwith increased rectificationofAMPA
receptors. Pooled RI calculations from the same set of experiments shown in F. I, Leptin increases in EPSC amplitude is reversed by
philanthotoxin (1M). J, Leptin increases synaptic transmissionbypromotingexocytosis ofAMPAreceptors. The leptin-induced increases
in EPSC amplitude are attenuated by blockers of exocytosis. Histogram of the pooled data showing the relative effects of leptin on EPSC
amplitude in the presence of NEM (5mM; filled triangles), brefeldin A (5M; open triangles), or bafilomycin (1M; open circles) versus
control (filled circles).
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Leptin increases surface GluR1 expression via an NMDA
receptor-dependent process
NMDA receptor activation is required for LTP induction (Col-
lingridge et al., 1983) and the membrane insertion of AMPA
receptors during LTP (Man et al., 2003). To verify whether the
effects of leptin involved NMDA recep-
tors, the effects of the competitive NMDA
receptor antagonist D-AP5 were assessed.
D-AP5 (50 M; 30 min) had no effect on
surface GluR1 staining (96.1  3.5% of
control; n  37; p  0.05) per se. How-
ever, the leptin increase in GluR1 surface
staining (141  7.7%; n  37) was re-
duced to 109  3.8% of control (n  37;
p	 0.05) in D-AP5 (Fig. 3A,B). The abil-
ity of leptin to increase synaptic strength
was attenuated in the presence of D-AP5
such that leptin increased synaptic trans-
mission to only 103 9%of baseline (n
6; p	 0.05), an effect significantly differ-
ent to interleaved control experiments
(n  6; p  0.05) (Fig. 3C,D). We also
evaluated whether leptin altered the mag-
nitudeofNMDAreceptor–mediatedEPSCs
as leptin enhances pharmacologically iso-
lated NMDA EPSCs in juvenile hippocam-
pus (Shanley et al., 2001). Similarly, in
adult hippocampus leptin (25 nM) in-
creased the amplitude of NMDA EPSCs
(175 9%of control; n 5; p 0.05), an
effect that readily reversed on leptinwash-
out. The leptin-induced increase in EPSCs
was associated with a significant increase
in theNMDA receptor–mediated compo-
nent of the EPSC (amplitude of EPSC at
40 mV, at 60 ms latency) to 131 11%
of control (n  6; p  0.05), but no
change in the AMPA component (initial
slope of EPSC at 40 mV) was detected
(102  5%; n  6; p 	 0.05). This small
increase in NMDA receptor current is
likely to be sufficient for the NMDA
receptor-dependent enhancement of syn-
aptic strength by leptin.However, to show
conclusively that synaptic activation of
NMDA receptors was required, a two-
pathway experiment was performed such
that during leptin application stimulation
was stopped in the test pathway butmain-
tained in the control pathway. Under
these conditions, leptin failed to signifi-
cantly increase synaptic transmission in
the test pathway (109 10%; n 5; p	
0.05) whereas leptin markedly increased
EPSCs in the control path (188  14%;
n  5; p  0.001) (Fig. 3E). These data
indicate that leptin increases the density
of functional AMPA receptors at hip-
pocampal synapses via a process requiring
the synaptic activation of NMDA
receptors.
It is well established that NMDA re-
ceptors are highly permeable to Ca2 and
that Ca2 influx via NMDA receptors is pivotal for various forms
of activity-dependent changes in synaptic efficacy (Nicoll and
Malenka, 1999). Thus, as the leptin-driven increase in synaptic
strength requires the synaptic activation of NMDA receptors, we
examined whether Ca2 influx via NMDA receptors was also
Figure 3. Leptin increases surface GluR1 expression via an NMDA receptor-dependent process. A, Representative confocal
images of surface GluR1 labeling in cultures treated with AP5 (50M; left) or in AP5 and leptin (50 nM; right). The leptin increase
in surface GluR1 staining was blocked by AP5. B, Pooled data showing relative changes in surface GluR1 staining in control
conditions, after addition of leptin or D-AP5, and in the presence of D-AP5 and leptin.C, Representative experiment demonstrating
that D-AP5 prevented the increase in EPSC amplitude by leptin in hippocampal slices. Top, Example traces are shown for the time
points indicated. Calibration: 50 pA, 50ms.D, Pooled data of the experiment illustrated in C comparing the effects of leptin in the
absence (open circles) and presence (filled circles) of AP5. E, Pooled data illustrating the effects of leptin in a two-pathway
experiment. In the test pathway (filled circles) synaptic stimulation was stopped during application of leptin. In contrast stimula-
tion was maintained in the control path (open circles). Leptin failed to significantly alter synaptic transmission in the absence of
synaptic transmission.
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required for this effect. In this series of
experiments, whole-cell recordings were
made using recording pipettes containing
the Ca2 chelator, BAPTA (10mM). After
at least 30 min dialysis with the BAPTA-
containing solution, application of leptin
failed to significantly alter synaptic trans-
mission (107  14% of baseline; n  4;
p 	 0.05), indicating that an increase in
intracellular Ca 2 is required for the
leptin-dependent facilitation of synap-
tic transmission.
Leptin-induced increase in surface
GluR1 is correlated with an increase
in PtdIns(3,4,5)P3 levels
PI 3-kinase is a key element of neuronal
leptin receptor-driven signaling (Harvey,
2007), and it is required for AMPA recep-
tor insertion during LTP (Man et al.,
2003). As PI 3-kinase phosphorylates
PtdIns(4,5)P2 into PtdIns(3,4,5)P3, the
increase in surface GluR1 may be due to
enhanced PtdIns(3,4,5)P3 levels. To
address this, dual labeling was used to si-
multaneously compare surface GluR1
staining and the intracellular levels of
PtdIns(3,4,5)P3 in cultures. Leptin (25
nM; 30 min) increased surface GluR1
staining (163  9.1% of control; n  30;
p  0.001) with a parallel increase in
PtdIns(3,4,5)P3 staining (173  8.3% of
control; n  30; p  0.001) (Fig. 4A,B).
Shorter-duration applications of leptin (5
min) increased PtdIns(3,4,5)P3 staining
(147  8.3% of control; n  25; p 
0.001) with no significant alteration in
surface GluR1 staining (106  5.1% of
control; n 25; p	 0.05), suggesting that
leptin increases PtdIns(3,4,5)P3 levels
which in turn drives the alterations in
GluR1 trafficking.
We further characterized the connec-
tion between surface GluR1 expression
and PI 3-kinase/PtdIns(3,4,5)P3 using the
well characterized PI 3-kinase inhibitors
wortmannin and LY294002, because pro-
cesses dependent on class I PI 3-kinase-
generated PtdIns(3,4,5)P3 are sensitive to
these inhibitors. Blockade of PI 3-kinase
activity with wortmannin (10 nM; 30min)
or LY294002 (10 M; 30 min) had no ef-
fect on surface GluR1 or PtdIns(3,4,5)P3
levels (Fig. 4C). However, wortmannin
reduced the leptin driven increase in
GluR1 surface staining to 107  4.5%
Figure 4. Leptin increases surface GluR1 via a PI 3-kinase-dependent increase in PtdIns(3,4,5)P3 levels. A, Representative
confocal images of surfaceGluR1 (green) andPtdIns(3,4,5)P3 (red) staining in control and leptin-treatedneurons. Leptin (50nM; 30
min) increased GluR1 surface labeling and PtdIns(3,4,5)P3 levels. B, Pooled data showing relative changes in surface GluR1 (open
bars) and PtdIns(3,4,5)P3 (filled bars) in control conditions and after leptin exposure for 5min and 30min. C, Pooled data showing
relative changes in surface GluR1 (open bars) and PtdIns(3,4,5)P3 (filled bars) labeling in control conditions and after leptin (50 nM;
30 min), wortmannin (50 nM; 30 min), or LY294002 (10M; 30 min) alone, or in the presence of either wortmannin or LY294002
and leptin. D, Pooled and normalized data for all experiments showing that LY294002 (10M) prevents potentiation of EPSCs by
4
leptin (25 nM) in slices. Spermine (0.1mM) was included in the
recording pipette, and cells were depolarized to 40 mV
where indicated (gray bars). E, Representative examples of
EPSCs obtained at time points indicated in D.
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(n  33; p 	 0.05), compared with 146  5.3% (n  33; p 
0.001) in control. The leptin-induced increase in PtdIns(3,4,5)P3
levels was also reduced from 152 8.2% in control (n 30; p
0.01) to 109 6.9% (n 30; p 0.01) in wortmannin. Exposure
to LY294002 also attenuated leptin’s effects such that the increase
in surface GluR1 staining by leptin was reduced from 138 5.2%
to 106  4.4% (n  29; p 	 0.05), whereas the leptin-induced
increase in PtdIns(3,4,5)P3 staining was reduced from 147 
5.6% (n 35; p 0.01) to 109 7.1% (n 35; p 0.05) in the
presence of LY294002. In parallel studies the ability of leptin to
enhance excitatory synaptic strength was prevented by prior ex-
posure to either LY294002 (n 6) (Fig. 4D) or wortmannin (n
6). LY294002 also prevented any significant leptin-driven changes
in AMPA receptor rectification (1.38 0.14 to 1.43 0.20; n 6;
p 	 0.05). These data indicate that a PI 3-kinase-dependent
process underlies the leptin-driven in-
crease in GluR1 surface expression and
PtdIns(3,4,5)P3 levels.
PTEN and phosphorylated PTEN are
localized to distinct subcellular
compartments in hippocampal neurons
Although our data suggest that leptin in-
creases surface GluR1 expression, via a PI
3-kinase-dependent increase in PtdIns
(3,4,5)P3, the possibility that leptin uses an
alternative mechanism to raise intracellular
PtdIns(3,4,5)P3 levels cannotbe excluded. It
is known that the PtdIns(3,4,5)P3 levels
are also regulated by PTEN. Although
PTENplays an important role in the CNS,
there is limited information about its cel-
lular distribution in neurons. Thus, ini-
tially the functional localization of PTEN
was assessed in cultured hippocampal
neurons immunocytochemically. PTEN
labeling was present on principle neurons
in hippocampal cultures. Comparison of
PTEN immunoreactivity with surface
cannabinoidCB1 receptor labeling, an ax-
onal marker (Coutts et al., 2001), and sur-
face GluR1 staining which is restricted to
somato-dendritic regions, demonstrated
high levels of PTEN expression within
these neuronal compartments (Fig. 5A).
Dual labeling with an antibody against
synapsin-1 also revealed clusters of PTEN
labeling associated with synapses (data
not shown).
As the phosphorylation status of PTEN
is important for its function, the distribu-
tion of PTEN when phosphorylated on
one key site, threonine 366 (P366-PTEN),
was compared. In contrast to PTEN dis-
tribution, the phosphorylated form of
PTEN exhibited a very distinct cellular
distribution such that labeling was re-
stricted to specific submembrane cyto-
plasmic regions within somata and
dendrites. Dual labeling studies demon-
strated that when phosphorylated, PTEN
localized to the Golgi apparatus as P366-
PTEN labeling directly correlatedwith the
Golgi marker, mannosidase II, but to a much lesser extent with
the endosomal markers Rab7 (20  5% colocalization; n  6)
(Fig. 5B) and Rab5 (17 4% colocalization; n 4). Thus, these
data suggest that phosphorylation of PTEN significantly alters the
subcellular localization of PTEN such that it is limited to the
Golgi apparatus.
Leptin promotes PTEN inactivation in hippocampal neurons
One way of modulating PTEN function is by phosphorylation,
which results in inactivation of this phosphatase (Downes et al.,
2007). Recent studies have implicated increased phosphorylation
and inhibition of PTEN in leptin receptor coupling to KATP chan-
nels (Ning et al., 2006; Plum et al., 2006). Thus, we examined the
effects of leptin on P366-PTEN labeling in hippocampal neu-
rons. Leptin produced an increase in P366-PTEN labeling to
Figure 5. Cellular distribution of PTEN in hippocampal neurons. A, Representative confocal images of PTEN and surface GluR1
labeling in hippocampal neurons (9DIC). The merged image shows that PTEN is associated with somato-dendritic regions.
B, Confocal images of PTEN, surface CB1 receptor labeling, and the merged image. C, D, Representative confocal images of
P366-PTEN (C,D) and either Rab7 (C) ormannosidase II (D) labeling. The correspondingmerged images are also displayed in C and
D. Scale bars, 10m.
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123  5.2% of control (n  34; p 
0.01) whereas the levels of PTEN pro-
tein were unaffected by leptin (104 
3.6% of control; n  35; p 	 0.05) (Fig.
6A,B).
In parallel biochemical studies, the ef-
fects of leptin exposure on total PTEN and
P366-PTENwere examined in hippocam-
pal slices from both Zucker fa/fa and lean
adult rats. Exposure to leptin (25 nM; 15
min) resulted in amodest increase in P366
PTEN levels in slices fromZucker lean rats
(263  73%, n  6) (Fig. 6C), with no
change in total PTEN levels. In contrast,
leptin had no effect on P366-PTEN or to-
tal PTEN levels in slices from Zucker fa/fa
rats. These data are consistent with leptin
increasing phosphorylation of PTEN via
activation of the leptin receptor.
As phosphorylation of PTEN pro-
motes its inactivation with a resultant in-
crease in PtdIns(3,4,5)P3, we compared
the levels of PtdIns(3,4,5)P3 and P366-
PTEN. Leptin increased P366-PTEN
staining to 131 4.2%of control (n 27;
p  0.05) with a concomitant increase in
PtdIns(3,4,5)P3 labeling to 140 4.9% of
control (n  27; p  0.05). This suggests
that leptin increases PtdIns(3,4,5)P3 levels
at least in part via PTEN phosphorylation
and hence inhibition of PTEN activity.
As PTEN is phosphorylated by the pro-
tein kinase, CK2 (Torres and Pulido,
2001) and CK2 activity is increased after
NMDA receptor activation (Charriaut-
Marlangue et al., 1991), we examined the
effects of a selective CK2 inhibitor, 2-dime-
thyl-amino-4,5,6,7-tetrabromobenzima-
dazole (DMAT; Pagano et al., 2004).
Exposure to DMAT (10 M) prevented
the leptin-driven increase in P366-PTEN
(100  4%; n  27; p 	 0.05) (Fig. 6D)
and surface GluR1 staining (105  10%;
n  27; p 	 0.05) (Fig. 6D). Leptin also
failed to increase excitatory synaptic
strength (110  12% of control; n  5;
p 	 0.05) in DMAT-treated slices com-
pared with control slices (198  15% of
control; n 3) (Fig. 6E). These data indi-
cate that CK2 underlies phosphorylation
Figure 6. The leptin-driven increase in PtdIns(3,4,5)P3 levels is associated with increased phosphorylation of PTEN. A, Repre-
sentative confocal images of P366-PTEN and PTEN labeling in control conditions and after leptin exposure (30 min). Leptin
increased P366-PTEN staining without altering global PTEN staining. Scale bars, 10m. B, Histogram of pooled data showing
relative changes in P366-PTEN (open bars) and PTEN (filled bars) staining in control and leptin-treated neurons. C, The histogram
shows themean normalized P366-PTEN (filled bars) and total PTEN (open bars) levels in control and leptin (25 nM; 15min)-treated
4
slices fromZucker leanand fa/fa rats. Corresponding represen-
tative Western blots of P366-PTEN and total PTEN are shown
directly above the histogram. D, Pooled data showing the ef-
fects of leptin on P366-PTEN immunoreactivity (filled bar)
and surface GluR1 staining (gray bars) staining in control
conditions and after DMAT exposure. E, In slices, the
leptin-induced increase in EPSCs was reduced in the pres-
ence of DMAT (open circles) relative to control (filled cir-
cles). Top, Example traces are shown for the time points
indicated. Calibration: 50 pA, 50 ms.
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of PTEN and subsequent alterations in glutamate receptor traf-
ficking and synaptic strength by leptin.
Inhibition of PTENmimics and occludes the effects of leptin
Our data suggest that leptin promotes increases in PtdIns(3,4,5)P3
and surface GluR1 levels via PTEN inhibition. Consequently, to
explore the role of PTEN further, we examined the effects of two
dominant-negative PTENmutants on surface GluR1 staining. Cul-
tured hippocampal neurons were transfected with either one of the
PTENmutants (PTENC124S or PTENG129E) or the empty vector
(EGFP-C2). Cells transfected with either PTEN C124S or PTEN
G129E showed a significant increase in surface GluR1 labeling rela-
tive to control cells transfected with the empty vector (120.2 4%,
p 0.01 and 122.7 3%, p 0.001 relative
tocontrol respectively;n27 foreach) (Fig.
7A,B). Leptin failed to increase surface
GluR1 staining in cells transfected with
PTENC124SorPTENG129E (106.14%,
p	 0.05 and 104.3 3%, p	 0.05 relative
tocontrol respectively;n27 foreach) (Fig.
7Bii). Conversely, leptin increased surface
GluR1 expression in neighboring nontrans-
fected cells (130.7 2%, p 0.001 relative
to control; n 81). These data support the
idea that PTEN inhibition increases GluR1
surface expression and that leptin increases
surface GluR1 via inhibition of PTEN.
We also examined the impact of PTEN
inhibition on the properties ofmEPSCs in
primary hippocampal neurons. Cells were
transfected with either of two dominant-
negative PTEN constructs, G129E or
C124S, and the amplitude and frequency of
mEPSCs were compared with neighboring
nontransfected control cells. Application of
leptin (25 nM; 15 min) resulted in a persis-
tent increase in the amplitude of mEPSCs
(amplitude, 141 10% of baseline 20 min
after leptin washout, n 6, p 0.01) (Fig.
7C) with no significant change in mEPSC
frequency. This effect of leptin was com-
pletely reversed (to 106 21% of baseline;
n  3) by addition of the selective antag-
onist for GluR2-lacking AMPA receptors,
philanthotoxin. In contrast, application
of leptin to cells transfected with either
dominant-negative PTEN construct,
G129E or C124S failed to alter mEPSC
amplitude (108  12% and 104  8% of
baseline 20 min after leptin, respectively;
n 4; p	 0.05 for each) (Fig. 7Ci). Fur-
thermore, cells transfected with either
G129E or C124S showed significantly
higher mean basal mEPSC amplitudes
(139  12% and 132  13% of control)
(Fig. 7Cii,Ciii) with no significant change
in mEPSC frequency. In addition, appli-
cation of philanthotoxin reduced the
mean amplitude of mEPSCs recorded
from cells transfected with either G129E
or C124S to that similar to neighboring
control cells (amplitude, 103  20% and
103  20% of control; n  4 for each)
while having no effect on basal transmission of neighboring con-
trol cells (Fig. 7Cii). Thus, these data indicate that PTEN inhibi-
tion selectively increases functional expression of GluR1 at
hippocampal synapses and that the ability of leptin to deliver
GluR1 subunits to synapses is blocked following inhibition of
PTEN.
As low concentrations of the phosphatase inhibitor bisperox-
ovanadium (bpV) has been shown to specifically inhibit PTEN
(Schmid et al., 2004), the effects of pharmacological inhibition of
PTEN with bpV were also assessed. To determine the functional
effects of PTEN inhibition, the effects of bpV on evoked EPSCs
were examined. Application of 100 nM bpV produced a robust
potentiation of EPSCs to 128 8%of baseline (n 6; p 0.001)
Figure 7. Inhibition of PTEN increases surface expression of GluR1 and occludes the effects of leptin.A, Representative confocal
images of surface GluR1 labeling in a cultured hippocampal neuron transfectedwith the PTEN G129E construct alongside untrans-
fected control neurons. Bi, Pooled data showing relative changes in surface GluR1 labeling in leptin-treated neurons or those
transfected with C124S or G129E. Bii, Pooled data showing relative changes in surface GluR1 labeling in response to leptin in
neurons transfectedwith either C124S or G129E. Ci, RepresentativemEPSCs recorded fromneurons transfectedwith either C124S,
G129E, or neighboring untransfected cells either immediately before or 15min after leptin application. Calibration; 20 pA, 100ms.
Cii, Pooled data showing normalized mEPSC amplitude in neighboring control neurons or those transfected with either C124S or
G129E (filled bars). Open bars show pooled data from the same cells 15 min after philanthotoxin application. Ciii, Pooled cumu-
lative probability plots showing a change in amplitude elicited by leptin (gray plot) in control neurons, but not in those transfected
with either G129E or C124S versus baseline (black plot).
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(Fig. 8A,B), which was not accompanied
by any significant change in PPR (n  6;
p 	 0.05) (Fig. 8C) or CV (n  6; p 	
0.05) (Fig. 8D), indicating the involve-
ment of a postsynaptic change. To deter-
mine whether bpV alters the GluR2
content of synaptic AMPA receptors, the
RI of evoked EPSCs were monitored. Ap-
plication of bpV (100 nM) increased EPSC
amplitude to 143  12% of control (n 
6) with a concomitant increase in the RI
from 1.3  0.1 to 2.0  0.1 (n  6; p 
0.05) (Fig. 8E–G). There was no signifi-
cant change in RI during interleaved
experiments with no spermine in the re-
cording pipette (n 6) (Fig. 8F,G).
In addition, application of bpV (50 nM;
30 min) increased surface GluR1 expres-
sion to 148 5.8%of control (n 46; p
0.01) (Fig. 8H, I). BpV also altered the
synaptic density of GluR1-containing
AMPA receptors as colocalization between
GluR1andsynapsin-1-positive siteswas sig-
nificantly enhanced from 31.8  2.6% to
43.2  3.9% (n  36; p  0.05); effects
not significantly different ( p 	 0.05) to
those of leptin (49.2  6.0% colocaliza-
tion; n  27; p  0.01) in paired exper-
iments. These data indicate that PTEN
inhibition promotes an increase in the
synaptic density of GluR1-containing
AMPA receptors.
As PTEN inhibition results in in-
creased PtdIns(3,4,5)P3 levels, we exam-
ined whether the increase in surface
GluR1 labeling was associated with in-
creased PtdIns(3,4,5)P3 levels. Treatment
with bpV increased surface GluR1 label-
ing (146  5.0% of control; n  38; p 
0.01) and PtdIns(3,4,5)P3 staining (154
6.2% of control; n  38; p  0.05) (Fig.
8H, I). These effects of bpV were not sig-
nificantly different to leptin as leptin re-
sulted in increases to 152 6.9% (n 29;
p  0.01: p 	 0.05 compared with bpV)
and 159  5.8% (n  29; p  0.01: p 	
0.05 compared with bpV) in GluR1 and
PtdIns(3,4,5)P3 labeling, respectively. These
data indicate that the effects of leptin are
mimickedbyPTEN inhibition.As leptin in-
creases the synaptic density of GluR1 via
PTEN inhibition, we determined whether
PTEN inhibition altered the effects of leptin
on GluR1 and PtdIns(3,4,5)P3 labeling.
Treatment of hippocampal neurons with
bpV occluded the effects of leptin such that
GluR1 staining was 155 7.1% of control
(n 32; p 0.01) whereas PtdIns(3,4,5)P3
labelingwas 161 6.2%of control (n 32;
p 0.001), in the combined presence of bpV and leptin (Fig. 8I).
Exposure of hippocampal slices to leptin also occluded the effects of
bpV such that leptin increased EPSC amplitude to 208  10% of
baseline (n 6), but subsequent application of bpV caused no sig-
nificant change in EPSC amplitude (n  6; p 	 0.05). These data
indicate that leptin increases the synaptic density of GluR1 via inhi-
bition of PTEN as bpV not only mimicked but also occluded the
effects of leptin.
Figure8. Theeffectsof leptinaremimickedandoccludedbyinhibitionofPTENbybpV.A,RepresentativeexperimentshowingthatbpV
potentiated EPSCs in hippocampal slices. Top, Example traces are shown for the times indicated. Calibration: 50 pA, 50ms.B, Pooled data
fromallexperiments.C,D,PPR(C)andCV(D)shownosignificantchangeinresponsetobpV.E,PooleddatashowingtheeffectsofbpVusing
spermine-containing pipettes (open circles). Interleaved control experiments using control intracellular solution are also shown (filled
circles). Cells were depolarized to40 mV at the times indicated (gray bars). F, Example EPSCs at40 mV and60 mV from an
experiment inE.Calibration:50pA,50ms.G,RI fromtheexperiments inE.H, I,PTENinhibition increasessurfaceGluR1andPtdIns(3,4,5)P3
levels and occludes the effects of leptin. H, representative confocal images of surface GluR1 (green), PtdIns(3,4,5)P3 (red) labeling and
correspondingmerged images in control conditions and after bpV exposure. bpV increased GluR1 and PtdIns(3,4,5)P3 labeling. I, Pooled
data of relative changes in PtdIns(3,4,5)P3 (open bars) and surface GluR1 (filled bars) labeling in control conditions, after bpV or leptin
treatment, and in the presence of bpV and leptin. Inhibition of PTENmimicked andoccluded the effects of leptin.
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Discussion
Evidence is growing that leptin has widespread actions in the
CNS. Several studies have implicated leptin in activity-dependent
synaptic plasticity and hippocampal-dependent learning and
memory (Harvey, 2007). AMPA receptor trafficking plays a piv-
otal role in regulating excitatory synaptic strength and numerous
growth factors, andhormonesmodulate this process (Poo, 2001).
In this studywe provide compelling evidence that leptin regulates
AMPA receptor trafficking in hippocampal neurons. Leptin pref-
erentially increased the density of GluR1 as opposed to GluR2
subunits as leptin was50-foldmore potent at increasing GluR1
surface expression in hippocampal cultures. Leptin also increased
GluR1 but not GluR2 surface expression in adult hippocampal
slices. Furthermore, leptin increased the synaptic density of
GluR1 subunits, suggesting that leptin promotes delivery of
GluR1-containing AMPA receptors to synapses. Indeed leptin
enhanced the density of polyamine-sensitive EPSCs, indicating
that leptin upregulates the synaptic expression of GluR2-lacking
AMPA receptors. The differential effects of leptin on GluR1 versus
GluR2 subunits displays parallels to the effects of BDNF andTNF-
on these subunits (Stellwagen and Malenka, 2006; Caldeira et al.,
2007). Our findings also support the notion that distinct cellular
mechanisms regulate the delivery of GluR1 and GluR2 to syn-
apses (Passafaro et al., 2001; Shi et al., 2001). Our data demon-
strate that blockade of exocytosis but not endocytosis attenuated
the effects of leptin on surface GluR1 expression and synaptic
transmission, indicating that leptin influences the synaptic den-
sity of AMPA receptors by promoting GluR1 exocytosis.
In contrast to the transient synaptic depression elicited by
leptin in juvenile hippocampus (Shanley et al., 2001; Xu et al.,
2008), leptin produced a persistent increase in excitatory synaptic
strength in adult, suggesting that the effects of leptin on synaptic
strength are developmentally regulated. However, leptin also
transiently depresses excitatory synaptic transmission in 6- to
8-week mouse hippocampus (Xu et al., 2008), suggesting that
modulation of excitatory synaptic transmission by leptin in adult
hippocampus is age dependent, or alternatively that species-
dependent differences underlie the differential effects of leptin on
synaptic transmission. We have shown that NMDA receptor ac-
tivation is required for facilitation of hippocampal LTP and LTD
induced by leptin (Shanley et al., 2001; Durakoglugil et al., 2005).
Leptin-driven dendritic morphogenesis requires the synaptic ac-
tivation of NMDA receptors (O’Malley et al., 2007). NMDA re-
ceptor activation also mediates delivery of GluR1 subunits to
hippocampal synapses by leptin as leptin-dependent increases in
surface GluR1 expression and EPSC amplitude were reduced by
D-AP5.Moreover, the increase in synaptic strength by leptin was
associated with an increase in NMDA receptor–mediated synap-
tic currents, and synaptic activation of NMDA receptors was re-
quired for the effects of leptin as leptin failed to increase synaptic
transmission when stimulation was stopped. Similarly, the syn-
aptic delivery of GluR1-containing AMPA receptors induced by
tetanic stimulation or chemical induction of LTP requires synap-
tic activation ofNMDA receptors (Passafaro et al., 2001; Shi et al.,
2001; Man et al., 2003).
How the synaptic activation of NMDA receptors contributes
to facilitation of synaptic transmission by leptin is not entirely
clear. However, influx of Ca2 via NMDA receptors is likely to
play a significant role as chelation of Ca2 ions with BAPTA
blocked the effects of leptin, and we have shown previously that
leptin has no effect on intracellular Ca2 levels (Shanley et al.,
2001). Recent studies indicate that CK2 is a downstream target of
NMDA receptors (Chung et al., 2004), and Ca2-dependent in-
creases in CK2 activity have also been reported after NMDA
receptor-dependent LTP (Charriaut-Marlangue et al., 1991).
Moreover, PTEN is phosphorylated by CK2 (Torres and Pulido,
2001), and our data indicate that CK2 activation is required for
leptin-driven increases in GluR1 surface expression and synaptic
transmission. Thus, it is feasible that leptin, via enhancing
NMDAreceptor activation, promotes an increase inCK2 activity,
which in turn results in phosphorylation and subsequent inhibi-
tion of PTEN.
Our data indicate that the effects of leptin on GluR1 traffick-
ing involve an increase in PtdIns(3,4,5)P3 levels secondary to
PTEN inhibition as the effects of leptin on surface GluR1 staining
were associated with increased PtdIns(3,4,5)P3 levels and eleva-
tions in PtdIns(3,4,5)P3 levels occurred before alteredGluR1 traf-
ficking. In agreement with previous studies (Man et al., 2003),
inhibitors of PI 3-kinase attenuated the effects of leptin on surface
GluR1 and PtdIns(3,4,5)P3 levels, consistent with PI 3-kinase-
dependent signaling underlying these effects. However, our studies
indicate that leptin trafficking of GluR1 to synapses is mediated
by a novel mechanism involving PTEN inhibition. Leptin in-
creased phosphorylation of PTEN, an effect associated with an
increase in PtdIns(3,4,5)P3 levels. Moreover, inhibition of PTEN
mimicked and occluded leptin-induced trafficking of GluR1 to
hippocampal synapses and facilitation of excitatory synaptic
transmission. The role of PTEN inhibition in hippocampal
leptin-driven signaling displays parallels to the role of PTEN in
the activation of hypothalamic KATP channels by leptin (Ning et
al., 2006; Plum et al., 2006). Indeed, genetic inactivation of hypo-
thalamic PTEN elevates PtdIns(3,4,5)P3-dependent signaling
which is pivotal for KATP channel activation by leptin (Plum et al.,
2006).
In most cells PTEN is constitutively active and thereby influ-
ences the basal levels of PtdIns(3,4,5)P3. Transgenic mouse stud-
ies indicate that regulation of PTEN occurs primarily via its
inhibition or reduced cellular expression which in turn enhances
PI 3-kinase-dependent signaling. Our studies show that leptin
regulates PTEN by increasing its phosphorylation which is likely
to result in inhibition of its phosphatase activity. Our data also
indicate that the cellular distribution of PTEN was altered after
phosphorylation as the phosphorylated form of PTEN localized
to the Golgi apparatus. In agreement with these findings, studies
in non-neuronal cells have shown that phosphorylation of PTEN
alters its subcellular localization (Leslie et al., 2008). As PTEN
needs to associate with the plasma membrane for its constitutive
activity, it is likely that translocation of PTEN to the Golgi appa-
ratus limits its ability to antagonize PI 3-kinase-dependent sig-
naling. However, it is not clear whether PTEN redistribution to
the Golgi directly influences AMPA receptor trafficking and ex-
citatory synaptic function. During exocytosis, membrane pro-
teins can be delivered directly from the trans-Golgi network to
the plasma membrane. The trans-Golgi network also regulates
the synaptic delivery of GluR1-containing AMPA receptors dur-
ing synaptic plasticity (Gerges et al., 2004). Thus, specific target-
ing of inactive phosphorylated PTEN to the Golgi may result in
highly localized elevations in PtdIns(3,4,5)P3 levels close to this
subcellular compartment. However, it is not clear how elevations
in PtdIns(3,4,5)P3 levels influence delivery of AMPA receptors to
synapses. As PtdIns(3,4,5)P3 modifies the activity of numerous
signaling molecules, including phosphoinositide-dependent ki-
nases and guanine nucleotide exchange factors (GEFs; Cantley,
2002), one ormore of these downstream targetsmay play a role in
this process. One potential target for PtdIns(3,4,5)P3 is Akt, a
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kinase that promotes phosphorylation and inhibition of glycogen
synthase kinase-3 (GSK-3). Indeed, nerve growth factor phos-
phorylates and inactivates PTEN, leading to GSK-3 inhibition
and axonal outgrowth (Arevalo and Rodríguez-Te´bar, 2006).
GSK-3 is also implicated in AMPA receptor trafficking, as
AMPA receptor insertion after chemical induction of hip-
pocampal LTP is associated with increased PI 3-kinase/Akt-
driven inhibition of GSK-3 (Peineau et al., 2007). Alterations
in PtdIns(3,4,5)P3 levels may promote structural rearrangement
of the actin cytoskeleton which in turn influences the synaptic
density of AMPA receptors (Zhou et al., 2001). Indeed, GEFs
control the activity and function of Rho GTPases, a family of
proteins that regulate the actin cytoskeleton. Moreover, one par-
ticular GEF, kalirin-7, associates with and controls the synaptic
expression of GluR1-containing AMPA receptors (Xie et al.,
2007).
Most evidence points to altering the phosphorylation status of
PTEN as the main mechanism for regulating PTEN function.
Changes in PTEN phosphorylation not only regulate its activity,
but also influence its association with PDZ domains from other
regulatorymolecules, including the scaffolding proteinsMAGI-2
and synapse-associated protein-97 (SAP97; Valiente et al., 2005;
Vazquez et al., 2001). As SAP97 is a membrane-associated guan-
ylate kinase (MAGUK) that regulates the insertion and synaptic
localization of GluR1-containing AMPA receptors (Rumbaugh
et al., 2003), leptin, by promoting PTENphosphorylation,may alter
PTEN/SAP-97 interactions, which influences GluR1 trafficking.
MAGI-2 is also linked to AMPA receptor trafficking as it interacts
with transmembrane AMPA receptor regulating proteins (TARPS),
and it links TARP/AMPA receptor complexes to other postsynaptic
molecules (Deng et al., 2006). MAGI-2 binding to PTEN enhances
PTEN-dependent suppression of PI 3-kinase/Akt activation (Wu et
al., 2000), whereas PTEN phosphorylation causes a conformational
change that reduces MAGI-2 binding to PTEN (Valiente et al.,
2005). Thus, our data are consistent with leptin promoting PTEN
phosphorylation which would reduce MAGI-2/PTEN interactions
and thereby enhance PI 3-kinase/Akt signaling and AMPA receptor
trafficking.
Leptin is a circulating hormone that is transported to most
brain regions via transport across the blood–brain barrier. Leptin
mRNA and protein have been detected in several brain regions,
including the hippocampus (Morash et al., 1999), and recent
studies have shown leptin production by the brain (Eikelis et al.,
2007). Thus, the concentration of leptin reaching hippocampal
synapses is likely to be derived from that released locally as well as
from peripheral sources. Several studies indicate that leptin
markedly influences the cellular events underlying hippocampal-
dependent learning and memory (Harvey, 2007). Indeed leptin
facilitates hippocampal LTP via enhancing NMDA receptor
function, and it promotes rapid changes in hippocampal den-
dritic morphology and synaptic density. The ability of leptin to
rapidly alter the synaptic density of GluR1-containing AMPA
receptors provides additional evidence in support of a role for
leptin in regulating hippocampal synaptic plasticity.
Evidence is accumulating that cognitive deficits occur in
leptin-insensitive rodents (Li et al., 2002) and are associated with
obesity-related diseases like type II diabetes. Recent studies have
linked altered leptin levels to neurodegenerative disorders as pa-
tients with Alzheimer disease display attenuated leptin levels
(Power et al., 2001). Studies in transgenic mice overexpressing
amyloid  indicate that leptin significantly reduces amyloid 
levels. As obesity and related disorders are thought to be a conse-
quence of blood–brain barrier resistance to leptin, resistance to
this hormone may contribute to cognitive deficits in diabetics
and in neurodegenerative disorders. Thus, the ability of leptin to
promote changes in the efficacy of excitatory synaptic transmis-
sion via rapid trafficking of AMPA receptor may be crucial for its
role not only in normal CNS function but also in neurological
disorders associated with leptin resistance or insensitivity.
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